SOBR Safe Faces Nasdaq Delisting, Ineligible for Standard Cure Period
SOBR sits 28% above its 52-week low of $0.663 on light trading volume (0.1× avg).
Summary
SOBR Safe, Inc. received a Nasdaq delisting notice on March 19, 2026, for failing to maintain the $1.00 minimum bid price for 30 consecutive business days. Critically, the company is ineligible for the standard 180-day cure period due to cumulative reverse stock splits exceeding 1-for-250. This highly material event, disclosed via an 8-K filing, signals significant financial distress and poses a severe threat to the company's public market listing. While SOBR Safe plans to appeal the decision, which temporarily stays the delisting, the underlying issues of low stock price and prior reverse splits are deeply concerning for investors. The outcome of the appeal will be the next major catalyst, as delisting would severely impact liquidity and investor confidence.
At the time of this announcement, SOBR was trading at $0.85 on OTC in the Technology sector, with a market capitalization of approximately $1.6M. The 52-week trading range was $0.66 to $7.70. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.